Toby Maher, MD, PhD: Improving Lung Function with ENV-101 Treatment of Idiopathic Pulmonary Fibrosis (HCPLive) - May 20, 2024 - "In a new interview during ATS 2024, the HCPLive editorial team spoke with the data's presenter Toby M. Maher, MD, PhD...Maher spoke on the findings on ENV-101 and their implications for IPF patients. 'The Hedgehog pathway is a pathway that is active during embryogenesis, so during the development of the fetus in the womb,' Maher explained. '...It appears that in people who develop pulmonary fibrosis, but also fibrosis of other organs, the Hedgehog pathway reactivates and is switched on again, for whatever reason. So within the fibrotic lung tissue, it again plays a role in proliferation and the generation of fibrotic tissue.'"
Interview • Video • Idiopathic Pulmonary Fibrosis
|